Watch Leading Oncology Specialists Discuss The Current Lung Cancer Landscape
Coming Soon
Chapters
1Epidemiology, Screening, and Staging of Lung Cancer2Treatment of Resectable and Unresectable Stage III NSCLC and LS-SCLC3Treatment of Metastatic NSCLC and ES-SCLCEpidemiology, Screening, and Staging of Lung Cancer
Treatment of Resectable and Unresectable Stage III NSCLC and LS-SCLC
Treatment of Metastatic NSCLC and ES-SCLC
Expert Panel
J. Jay Zhang, MD, PhD
Associate Professor
UT MD Anderson Cancer Center
Houston, Texas
Carl Gay, MD, PhD
Assistant Professor
UT MD Anderson Cancer Center
Houston, Texas
Xiuning Le, MD, PhD
Assistant Professor
UT MD Anderson Cancer Center
Houston, Texas
Program Objectives
Discuss biomarker testing and treatment options for metastatic NSCLC
Review considerations in the management of ES-SCLC
Explore ways to help manage treatment-related adverse events in patients with lung cancer
